Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gene therapy
|
| gptkbp:administeredBy |
intracerebral injection
|
| gptkbp:alternativeName |
OXB-102
|
| gptkbp:clinicalTrialPhase |
Phase 1/2
|
| gptkbp:deliveredBy |
lentiviral vector
|
| gptkbp:developedBy |
gptkb:Axovant_Gene_Therapies
|
| gptkbp:encodes |
gptkb:AADC
TH CH1 |
| https://www.w3.org/2000/01/rdf-schema#label |
AXO-Lenti-PD
|
| gptkbp:intendedUse |
gptkb:Parkinson's_disease
|
| gptkbp:mechanismOfAction |
restores dopamine synthesis
|
| gptkbp:status |
investigational
|
| gptkbp:targetTissue |
gptkb:putamen
|
| gptkbp:bfsParent |
gptkb:Sio_Gene_Therapies
|
| gptkbp:bfsLayer |
7
|